The Signal Response of IκBα Is Regulated by Transferable N- and C-Terminal Domains

REFERENCES

• Alkalay, I., A. Yaron, A. Hatzubai, A. Orian, A. Ciechanover, and Y. Ben-Neriah. 1995. Stimulation-dependent IκBα phosphorylation marks the NF-κB inhibitor for degradation via the ubiquitin-proteasome pathway. Proc. Natl. Acad. Sci. USA 92:10599–10603.
   PubMed Web of Science ®Google Scholar
• Aoki, T., Y. Sano, T. Yamamoto, and J.-I. Inoue. 1996. The ankyrin repeats but not the PEST-like sequences are required for signal-dependent degradation of IκBα. Oncogene 12:1159–1164.
   PubMedGoogle Scholar
• Baeuerle, P. A., and T. Henkel. 1994. Function and activation of NF-κB in the immune system. Annu. Rev. Immunol. 12:141–179.
   PubMed Web of Science ®Google Scholar
• Baldi, L., K. Brown, G. Franzoso, and U. Siebenlist. 1996. Critical role for lysines 21 and 22 in signal-induced ubiquitin-mediated proteolysis of IκBα. J. Biol. Chem. 271:376–379.
   PubMed Web of Science ®Google Scholar
• Baldwin, A. S. 1996. The NF-κB and IκB proteins: new discoveries and insights. Annu. Rev. Immunol. 14:649–683.
   PubMed Web of Science ®Google Scholar
• Barroga, C. F., J. K. Stevenson, E. M. Schwarz, and I. M. Verma. 1995. Constitutive phosphorylation of IκBα by casein kinase II. Proc. Natl. Acad. Sci. USA 92:7637–7641.
   PubMed Web of Science ®Google Scholar
• Beg, A. A., S. M. Ruben, R. I. Scheinman, S. Haskill, C. A. Rosen, and A. S. Baldwin. 1992. IκB interacts with the nuclear localization sequences of the subunits of NF-κB: a mechanism for cytoplasmic retention. Genes Dev. 6:1899–1913.
   PubMed Web of Science ®Google Scholar
• Beg, A. A., T. S. Finco, P. V. Nantermet, and A. S. Baldwin, Jr. 1993. Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of IκBα: a mechanism for NF-κB activation. Mol. Cell. Biol. 13:3301–3310.
   PubMed Web of Science ®Google Scholar
• Bours, V., G. Franzoso, V. Azarenko, S. Park, T. Kanno, K. Brown, and U. Siebenlist. 1993. The oncoprotein Bcl-3 directly transactivates through κB motifs via association with DNA-binding p50B homodimers. Cell 72:729–739.
   PubMed Web of Science ®Google Scholar
• Bours, V., P. R. Burd, K. Brown, J. Villalobos, S. Park, R.-P. Ryseck, R. Bravo, K. Kelly, and U. Siebenlist. 1992. A novel mitogen-inducible gene product related to p50/p105-NF-κB participates in transactivation through a κB site. Mol. Cell. Biol. 12:685–695.
   PubMed Web of Science ®Google Scholar
• Boyle, W.J., P. van der Geer, and T. Hunter. 1991. Phosphopeptide mapping and phosphoamino acid analysis by two-dimensional separation on thin-layer cellulose plates. Methods Enzymol. 201:101–149.
   PubMedGoogle Scholar
• Brockman, J. A., D. C. Scherer, T. A. McKinsey, S. M. Hall, X. Qi, W. Y. Lee, and D. W. Ballard. 1995. Coupling of a signal response domain in IκBα to multiple pathways for NF-κB activation. Mol. Cell. Biol. 15:2809–2818.
   PubMed Web of Science ®Google Scholar
• Brown, K., S. Gerstberger, L. Carlson, G. Franzoso, and U. Siebenlist. 1995. Control of IκBα proteolysis by site-specific, signal-induced phosphorylation. Science 267:1485–1491.
   PubMed Web of Science ®Google Scholar
• Brown, K., S. Park, T. Kanno, G. Franzoso, and U. Siebenlist. 1993. Mutual regulation of the transcriptional activator NF-κB and its inhibitor, IκBα. Proc. Natl. Acad. Sci. USA 90:2532–2536.
   PubMed Web of Science ®Google Scholar
• Chen, Z., J. Hagler, V. J. Palombella, F. Melandri, D. Scherer, D. Ballard, and T. Maniatis. 1995. Signal-induced site-specific phosphorylation targets IκB to the ubiquitin-proteasome pathway. Genes Dev. 9:1586–1597.
   PubMed Web of Science ®Google Scholar
• Chen, Z., L. Parent, and T. Maniatis. 1996. Site-specific phosphorylation of IκBα by a novel ubiquitination-dependent protein kinase activity. Cell 84:853–862.
   PubMed Web of Science ®Google Scholar
• Cordle, S. R., R. Donald, M. A. Read, and J. Hawiger. 1993. Lipopolysaccharide induces phosphorylation of MAD-3 and activation of c-Rel and related NF-κB proteins in human monocytic THP-1 cells. J. Biol. Chem. 268:11803–11810.
   PubMed Web of Science ®Google Scholar
• DiDonato, J., F. Mercurio, C. Rosette, J. Wu-Li, H. Suyang, S. Ghosh, and M. Karin. 1996. Mapping of the inducible IκB phosphorylation sites that signal its ubiquitination and degradation. Mol. Cell. Biol. 16:1295–1304.
   PubMed Web of Science ®Google Scholar
• Franzoso, G., V. Bours, V. Azarenko, S. Park, M. Tomita-Yamaguchi, T. Kanno, K. Brown, and U. Siebenlist. 1993. The oncoprotein Bcl-3 can facilitate NF-κB-mediated transactivation by removing inhibiting p50 homodimers from select κB sites. EMBO J. 12:3893–3901.
   PubMedGoogle Scholar
• Franzoso, G., V. Bours, V. Azarenko, S. Park, M. Tomita-Yamaguchi, T. Kanno, K. Brown, and U. Siebenlist. 1992. The candidate oncoprotein Bcl-3 is an antagonist of p50/NF-κB-mediated inhibition. Nature 359:339–342.
   PubMedGoogle Scholar
• Fuchs, S. Y., L. Dolan, R. J. Davis, and Z. Ronai. 1996. Phosphorylation-dependent targeting of c-Jun ubiquitination by Jun N-kinase. Oncogene 13:1531–1535.
   PubMedGoogle Scholar
• Ganchi, P., S.-C. Sun, W. C. Greene, and D. W. Ballard. 1992. IκB/MAD-3 masks the nuclear localization signal of NF-κB p65 and requires the transactivation domain to inhibit NF-κB p65 DNA binding. Mol. Biol. Cell. 3:1339–1352.
   PubMedGoogle Scholar
• Haskill, S., A. A. Beg, S. M. Tompkins, J. S. Morris, A. D. Yurochko, A. Sampson-Johannes, K. Mondal, P. Ralph, and A. S. Baldwin. 1991. Characterization of an immediate-early gene induced in adherent monocytes that encodes IκB-like activity. Cell 65:1281–1289.
   PubMed Web of Science ®Google Scholar
• Henkel, T., U. Zabel, K. van Zee, J. M. Muller, E. Fanning, and P. A. Baeuerle. 1992. Intramolecular masking of the nuclear localization signal and dimerization domain in the precursor for the p50 NF-κB subunit. Cell 68:1121–1133.
   PubMed Web of Science ®Google Scholar
• Israel, D., and R. J. Kaufman. 1989. Highly inducible expression from vectors containing multiple GRE’s in CHO cells overexpressing the glucocorticoid receptor. Nucleic Acids Res 17:4589–4604.
   PubMedGoogle Scholar
• Jaffray, E., K. M. Wood, and R. T. Hay. 1995. Domain organization of IκB-α and sites of interaction with NF-κB p65. Mol. Cell. Biol. 15:2166–2172.
   PubMedGoogle Scholar
• King, R. W., R. J. Deshaies, J.-M. Peters, and M. W. Kirschner. 1996. How proteolysis drives the cell cycle. Science 274:1652–1658.
   PubMed Web of Science ®Google Scholar
• Krappmann, D., F. G. Wulczyn, and C. Scheidereit. 1996. Different mechanisms control signal-induced degradation and basal turnover of the NF-κB inhibitor IκBα in vivo. EMBO J. 15:6716–6726.
   PubMed Web of Science ®Google Scholar
• Lin, R., P. Beauparlant, C. Makris, S. Meloche, and J. Hiscott. 1996. Phosphorylation of IκBα in the C-terminal PEST domain by casein kinase II affects intrinsic protein stability. Mol. Cell. Biol. 16:1401–1409.
   PubMedGoogle Scholar
• Lin, W.-C., and S. Desiderio. 1993. Regulation of V(D)J recombination activator protein RAG-2 by phosphorylation. Science 260:953–959.
   PubMed Web of Science ®Google Scholar
• Lin, Y.-C., K. Brown, and U. Siebenlist. 1995. Activation of NF-κB requires proteolysis of the inhibitor IκBα: signal-induced phosphorylation of IκBα alone does not release active NF-κB. Proc. Natl. Acad. Sci. USA 92:3003–3009.
   Google Scholar
• McElhinny, J. A., S. A. Trushin, G. D. Bren, N. Chester, and C. V. Paya. 1996. Casein kinase II phosphorylates IκBα at S-283, S-289, S-293, and T-291 and is required for its degradation. Mol. Cell. Biol. 16:899–906.
   PubMed Web of Science ®Google Scholar
• Ohno, H., G. Takimoto, and T. W. McKeithan. 1990. The candidate protooncogene, bcl-3 is related to genes implicated in cell lineage determination and cell cycle control. Cell 60:991–997.
   PubMed Web of Science ®Google Scholar
• Rodriguez, M., J. Wright, J. Thompson, D. Thomas, F. Baleux, J. L. Virelizier, R. T. Hay, and F. Arenzana-Seisedos. 1996. Identification of lysine residues required for signal-induced ubiquitination and degradation of IκBα in vivo. Oncogene 12:2425–2435.
   PubMed Web of Science ®Google Scholar
• Roff, M., J. Thompson, M. S. Rodriguez, J.-M. Jacque, F. Baleux, F. Arenzana-Seisdedos, and R. T. Hay. 1996. Role of IκBα ubiquitination in signal-induced activation of NF-κB in vivo. J. Biol. Chem. 271:7844–7850.
   PubMed Web of Science ®Google Scholar
• Rogers, S., R. Wells, and M. Rechsteiner. 1986. Amino acid sequences common to rapidly degraded proteins: the PEST hypothesis. Science 234:364–368.
   PubMed Web of Science ®Google Scholar
• Schuägger, H., and G. von Jagow. 1987. Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal. Biochem. 166:368–379.
   PubMedGoogle Scholar
• Scherer, D. C., J. A. Brockman, Z. J. Chen, T. Maniatis, and D. Ballard. 1995. Signal-induced degradation of IκBα requires site-specific ubiquitination. Proc. Natl. Acad. Sci. USA 92:11259–11263.
   PubMed Web of Science ®Google Scholar
• Schwarz, E. M., D. van Antwerp, and I. M. Verma. 1996. Constitutive phosphorylation of IκBα by casein kinase II occurs preferentially at serine 293: requirement for degradation of free IκBα. Mol. Cell. Biol. 16:3554–3559.
   PubMedGoogle Scholar
• Siebenlist, U., G. Franzoso, and K. Brown. 1994. Structure, regulation and function of NF-κB. Annu. Rev. Cell Biol. 10:405–455.
   PubMedGoogle Scholar
• Siegel, J. N. 1992. Preparation and analysis of phosphorylated proteins, p. 11.2.1–11.2.17. In J. A. Coligan, A. M. Kruisbeek, D. H. Margulies, E. M. Shevach, and W. Strober (ed.), Current protocols in immunology. John Wiley and Sons, New York, N.Y.
   Google Scholar
• Sun, S.-C., P. A. Ganchi, D. W. Ballard, and W. C. Greene. 1993. NF-κB controls expression of inhibitor IκBα: evidence for an inducible autoregulatory pathway. Science 259:1912–1915.
   PubMed Web of Science ®Google Scholar
• Sun, S.-C., J. Elwood, and W. C. Greene. 1996. Both amino- and carboxyterminal sequences within IκBα regulate its inducible degradation. Mol. Cell. Biol. 16:1058–1065.
   PubMed Web of Science ®Google Scholar
• Traenckner, E. B., H. L. Pahl, T. Henkel, K. N. Schmidt, S. Wilk, and P. A. Baeuerle. 1995. Phosphorylation of human IκBα on serines 32 and 36 controls IκB activation in response to diverse stimuli. EMBO J. 14:2876–2883.
   PubMed Web of Science ®Google Scholar
• Traenckner, E. B., S. Wilk, and P. A. Baeuerle. 1994. A proteasome inhibitor prevents activation of NF-κB and stabilizes a newly phosphorylated form of IκBα that is still bound to NF-κB. EMBO J. 13:5433–5441.
   PubMed Web of Science ®Google Scholar
• Van Antwerp, D. J., and I. M. Verma. 1996. Signal-induced degradation of IκBα: association with NF-κB and the PEST sequence in IκBα are not required. Mol. Cell. Biol. 16:6037–6045.
   PubMed Web of Science ®Google Scholar
• Whiteside, S. T., M. K. Ernst, O. LeBail, C. Laurent-Winter, N. Rice, and A. Israel. 1995. N- and C-terminal sequences control degradation of MAD3/ IκBα in response to inducers of NF-κB activity. Mol. Cell. Biol. 15:5339–5345.
   PubMed Web of Science ®Google Scholar
• Wulczyn, F. G., M. Naumann, and C. Scheidereit. 1992. Candidate protooncogene bcl-3 encodes a subunit-specific inhibitor of transcription factor NF-κB. Nature 358:597–599.
   PubMedGoogle Scholar